Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-22
2005-03-22
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S272000, C544S269000, C514S263200, C514S263220, C540S600000
Reexamination Certificate
active
06869947
ABSTRACT:
The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV of formula I, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity
REFERENCES:
patent: 6060481 (2000-05-01), LaNoue et al.
patent: 1054012 (1998-12-01), None
patent: WO 9402150 (1994-02-01), None
patent: WO 0202560 (2002-01-01), None
patent: WO 0224698 (2002-03-01), None
patent: WO 02068420 (2002-09-01), None
Holst et al., Diabetes, vol. 47, pp. 1663-1670 (1998).
Christiansen Lise Brown
Kanstrup Anders Bendtz
Kristiansen Marit
Lundbeck Jane Marie
Sams Christian Klarner
Berch Mark L.
Bork Richard W.
Green Reza
Habte Kahsay
Novo Nordisk A S
LandOfFree
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds that are inhibitors of the enzyme DPP-IV, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds that are inhibitors of the enzyme DPP-IV will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3380066